全文获取类型
收费全文 | 25498篇 |
免费 | 2608篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 125篇 |
儿科学 | 939篇 |
妇产科学 | 1405篇 |
基础医学 | 3062篇 |
口腔科学 | 329篇 |
临床医学 | 5688篇 |
内科学 | 4229篇 |
皮肤病学 | 299篇 |
神经病学 | 2737篇 |
特种医学 | 339篇 |
外科学 | 1961篇 |
综合类 | 267篇 |
一般理论 | 46篇 |
预防医学 | 3200篇 |
眼科学 | 390篇 |
药学 | 1491篇 |
中国医学 | 28篇 |
肿瘤学 | 1629篇 |
出版年
2023年 | 366篇 |
2022年 | 260篇 |
2021年 | 528篇 |
2020年 | 471篇 |
2019年 | 572篇 |
2018年 | 772篇 |
2017年 | 680篇 |
2016年 | 750篇 |
2015年 | 770篇 |
2014年 | 1063篇 |
2013年 | 1437篇 |
2012年 | 1705篇 |
2011年 | 1854篇 |
2010年 | 1096篇 |
2009年 | 1189篇 |
2008年 | 1527篇 |
2007年 | 1644篇 |
2006年 | 1615篇 |
2005年 | 1494篇 |
2004年 | 1478篇 |
2003年 | 1324篇 |
2002年 | 1225篇 |
2001年 | 259篇 |
2000年 | 165篇 |
1999年 | 262篇 |
1998年 | 342篇 |
1997年 | 308篇 |
1996年 | 262篇 |
1995年 | 244篇 |
1994年 | 183篇 |
1993年 | 186篇 |
1992年 | 142篇 |
1991年 | 142篇 |
1990年 | 129篇 |
1989年 | 104篇 |
1988年 | 84篇 |
1987年 | 78篇 |
1986年 | 68篇 |
1985年 | 91篇 |
1984年 | 75篇 |
1983年 | 99篇 |
1982年 | 95篇 |
1981年 | 85篇 |
1980年 | 85篇 |
1979年 | 55篇 |
1978年 | 59篇 |
1977年 | 46篇 |
1976年 | 58篇 |
1974年 | 40篇 |
1973年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Prof Wim Van Lerberghe Prof Zoe Matthews Endang Achadi Chiara Ancona James Campbell Amos Channon Luc de Bernis Prof Vincent De Brouwere Vincent Fauveau Helga Fogstad Marge Koblinsky Jerker Liljestrand Abdelhay Mechbal Susan F Murray Tung Rathavay Helen Rehr Fabienne Richard Petra ten Hoope-Bender Sabera Turkmani 《Lancet》2014
992.
Choice of Vein‐Harvest Technique for Coronary Artery Bypass Grafting: Rationale and Design of the REGROUP Trial
下载免费PDF全文
![点击此处可从《Clinical cardiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Marco A. Zenati MD MSc J. Michael Gaziano MD MPH Joseph F. Collins ScD Kousick Biswas PhD Jennifer M. Gabany MSN CRNP CCRC Jacquelyn A. Quin MD MPH Jerene M. Bitondo PA‐C Faisal G. Bakaeen MD Rosemary F. Kelly MD A. Laurie Shroyer PhD Deepak L. Bhatt MD MPH 《Clinical cardiology》2014,37(6):325-330
The Randomized Endo‐vein Graft Prospective (REGROUP) trial ( ClinicalTrials.gov NCT01850082) is a randomized, intent‐to‐treat, 2‐arm, parallel‐design, multicenter study funded by the Cooperative Studies Program (CSP No. 588) of the US Department of Veterans Affairs. Cardiac surgeons at 16 Veterans Affairs (VA) medical centers with technical expertise in performing both endoscopic vein harvesting (EVH) and open vein harvesting (OVH) were recruited as the REGROUP surgeon participants. Subjects requiring elective or urgent coronary artery bypass grafting using cardiopulmonary bypass with use of ≥1 saphenous vein graft will be screened for enrollment using pre‐established inclusion/exclusion criteria. Enrolled subjects (planned N = 1150) will be randomized to 1 of the 2 arms (EVH or OVH) after an experienced vein harvester has been assigned. The primary outcomes measure is the rate of major adverse cardiac events (MACE), including death, myocardial infarction, or revascularization. Subject assessments will be performed at multiple times, including at baseline, intraoperatively, postoperatively, and at discharge (or 30 days after surgery, if still hospitalized). Assessment of leg‐wound complications will be completed at 6 weeks after surgery. Telephone follow‐ups will occur at 3‐month intervals after surgery until the participating sites are decommissioned after the trial's completion (approximately 4.5 years after the full study startup). To assess long‐term outcomes, centralized follow‐up of MACE for 2 additional years will be centrally performed using VA and non‐VA clinical and administrative databases. The primary MACE outcome will be compared between the 2 arms, EVH and OVH, at the end of the trial duration. 相似文献
993.
Oxidative stress, apoptosis, and fibrosis may play a major role in the development of radiation‐induced liver damage. Betaine, a native compound widely present in beetroot, was reported to possess hepato‐protective properties. The objective of this study was to investigate the influence of betaine on radiation‐induced liver damage. Animals were exposed to 9 Gy applied in 3 doses of 3 Gy/wk. Betaine (400 mg/kg/d), was orally supplemented to rats after the first radiation dose, and daily during the irradiation period. Animals were sacrificed 1 day after the last dose of radiation. The results showed that irradiation has induced oxidative stress in the liver denoted by a significant elevation in malondialdehyde, protein carbonyl, and 8‐hydroxy‐2‐deoxyguanosine with a significant reduction in catalase activity and glutathione (GSH) content. The activity of the detoxification enzyme cytochrome P450 (CYP450) increased while GSH transferase (GSH‐T) decreased. The activity of the apoptotic marker caspase‐3 increased concomitant with increased hyaluronic acid, hydroxyproline, laminin (LN), and collagen IV. These alterations were associated with a significant increase of gamma‐glutamyl transferase, alkaline phosphatase and alanine and aspartate aminotransferase markers of liver dysfunction. Betaine treatment has significantly attenuated oxidative stress, decreased the activity of CYP450, enhanced GSH‐T, reduced the activity of caspase‐3, and the level of fibrotic markers concomitant with a significant improvement of liver function. In conclusion, betaine through its antioxidant activity and by enhancing liver detoxification and reducing apoptosis may alleviate the progression of liver fibrosis and exert a beneficial impact on radiation‐induced liver damage. 相似文献
994.
Cornelia Zeidler Ulrike A.H. Grote Anna Nickel Beate Brand G?ran Carlsson Emília Cortes?o Carlo Dufour Caroline Duhem Gundula Notheis Helen A. Papadaki Hannah Tamary Geir E. Tj?nnfjord Fabio Tucci Jan Van Droogenbroeck Christiane Vermylen Jaroslava Voglova Blanca Xicoy Karl Welte 《Haematologica》2014,99(8):1395-1402
Long-term granulocyte-colony stimulating factor treatment has been shown to be safe and effective in severe chronic neutropenia patients. However, data on its use during pregnancy are limited. To address this issue, we analyzed all pregnancies reported to the European branch of the Severe Chronic Neutropenia International Registry since 1994. A total of 38 pregnancies in 21 women with chronic neutropenia (16 pregnancies in 10 women with congenital, 10 in 6 women with cyclic, 12 in 5 women with idiopathic neutropenia) were reported. Granulocyte-colony stimulating factor was administered throughout pregnancy in 16 women and for at least one trimester in a further 5 women. No major differences were seen between treated and untreated women with respect to pregnancy outcome, newborn complications and infections. In addition, we evaluated the genetic transmission of known or suspected genetic defects in 16 mothers having 22 newborns as well as in 8 men fathering 15 children. As a proof of inheritance, neutropenia was passed on to the newborn in 58% from female and in 62% from male patients with ELANE mutations, but also to some newborns from parents with unknown gene mutation. Based on our results, granulocyte-colony stimulating factor therapy has been shown to be safe for mothers throughout pregnancies and for newborns without any signs of teratogenicity. With an increasing number of adult patients, genetic counseling prior to conception and supportive care of mothers during pregnancy are crucial. The acceptance of having affected children may reflect the high quality of life obtained due to this treatment. 相似文献
995.
996.
997.
Charlotte Bradbury Kate Fletcher Yongzhong Sun Carl Heneghan Chris Gardiner Andrea Roalfe Pollyanna Hardy Debbie McCahon Gail Heritage Helen Shackleford FD Richard Hobbs David Fitzmaurice 《British journal of haematology》2020,188(6):962-975
Venous thromboembolism (VTE) is prevalent and impactful, with a risk of death, morbidity and recurrence. Post-thrombotic syndrome (PTS) is a common consequence and associated with impaired quality of life (QoL). The ExACT study was a non-blinded, prospective, multicentred randomised controlled trial comparing extended versus limited duration anticoagulation following a first unprovoked VTE (proximal deep vein thrombosis or pulmonary embolism). Adults were eligible if they had completed ≥3 months anticoagulation (remaining anticoagulated). The primary outcome was time to first recurrent VTE from randomisation. The secondary outcomes included PTS severity, bleeding, QoL and D-dimers. Two-hundred and eighty-one patients were recruited, randomised and followed up for 24 months (mean age 63, male:female 2:1). There was a significant reduction in recurrent VTE for patients receiving extended anticoagulation [2·75 vs. 13·54 events/100 patient years, adjusted hazard ratio (aHR) 0·20 (95% confidence interval (CI): 0·09 to 0·46, P < 0·001)] with a non-significant increase in major bleeding [3·54 vs. 1·18 events/100 patient years, aHR 2·99 (95% CI: 0·81–11·05, P = 0·10)]. Outcomes of PTS and QoL were no different between groups. D-dimer results (on anticoagulation) did not predict VTE recurrence. In conclusion, extended anticoagulation reduced VTE recurrence but did not reduce PTS or improve QoL and was associated with a non-significant increase in bleeding. Results also suggest very limited clinical utility of D-dimer testing on anticoagulated patients. 相似文献
998.
Washing of red cells is sometimes performed to reduce allergic reactions due to contaminating plasma proteins or to reduce the concentration of potassium accumulating in the supernatant of red cells during storage as an alternative to transfusion of fresher red cells in patients at risk of hyperkalaemia. There are a variety of methods for washing red cells, and the laboratory data suggest that variables such as age of red cell before washing, washing method and solution, storage medium and length of storage time after washing can all effect the final red cell quality. Studies suggest that washing removes 90–95% plasma, but the proportion of units below 0·05 mg/dl IgA (equivalent to IgA deficient) is variable dependent upon methods used. Although potassium levels are reduced immediately following washing, the rate of leakage following subsequent storage is method-dependent, requiring careful consideration of shelf life if potassium reduction is the goal. Other markers of red cell quality such as haemolysis are negatively impacted by washing so a reduced shelf life compared to standard red cells is appropriate, especially following irradiation. Data from animal models and clinical studies on possible additional benefits of washing, such as reduced lung or kidney injury, are mixed, ranging from some benefit to some harm, and further studies are warranted. 相似文献
999.
1000.
David B. Reuben MD Thomas M. Gill MD Alan Stevens PhD Jeff Williamson MD Elena Volpi MD PhD Maya Lichtenstein MD Lee A. Jennings MD MSHS Zaldy Tan MD Leslie Evertson DNP RN GNP-BC David Bass PhD Lisa Weitzman MSSA LISW-S ASW-G C-ASWCM Martie Carnie Nancy Wilson MA MSW Katy Araujo MPH Peter Charpentier MPH Can Meng MS MPH Erich J. Greene PhD James Dziura PhD Jodi Liu PhD MSPH MSE BSE Erin Unger Mia Yang MD Katherine Currie BSPH MAT Kristin M. Lenoir MPH Aval-NaʼRee S. Green MD Sitara Abraham MPH Ashley Vernon MPH Rafael Samper-Ternent MD PhD Mukaila Raji MD MSc Roxana M. Hirst MS Rebecca Galloway PT PhD Glen R. Finney MD Ilene Ladd MS Alanna Kulchak Rahm PhD MS CGC Pamela Borek MSN RN-C Peter Peduzzi PhD 《Journal of the American Geriatrics Society》2020,68(11):2492-2499